The Korean guideline for thyroid cancer screening

Journal of the Korean Medical Association

Volumn 58, Issue 4, 2015, Pages 302-312

  Yi, Ka Hee ^a   Kim, Soo Young ^b   Kim, Do Hoon ^c   Kim, Sun Wook ^d   Na, Dong Gyu ^e   Lee, You Jin ^f   Chung, Ki Wook ^g   Choi, Kui Son ^f   Koh, Yoon Woo ^h   Kim, Won Bae ^g   Nam, Kee Hyun ⁱ   Baek, Seung Kuk ^j   Baek, Jung Hwan ^g   Lee, Soon Young ^k   Jung, Yuh Seok ^f   Cho, Jung Jin ^l   Ju, Young Su ^b   Dang, Ji Yeon ^f   Kim, Yeol ^f   Lee, Won Chul ^m  

^a Seoul National University Boramae Hospital   (South Korea)

^b Hallym University   (South Korea)

^c Korea University   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f National Cancer Center   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Yonsei University College of Medicine   (South Korea)

^j Korea University College of Medicine   (South Korea)

^k Ajou University School of Medicine   (South Korea)

^l Hallym University College of Medicine   (South Korea)

^m The Catholic University of Korea College of Medicine   (South Korea)

more..

Author keywords

Cancer screening; Evidence; Guideline; Thyroid cancer; Ultrasonography

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; EARLY DIAGNOSIS; ECHOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; KOREA; MEDICAL EXPERT; MORBIDITY; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; SEX RATIO; THYROID CANCER;

EID: 84928502340     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2015.58.4.302     Document Type: Article

References (23)

1. National Cancer Information Center. Korea cancer registry statistics 2012 [Internet]. Goyang: National Cancer Information Center [cited 2015 Apr 9]. Available from: http://www.cancer.go.kr/mbs/cancer/jsp/album/gallery.jsp?addCancerTitle=&spage=1&boardId=31817&boardSeq=8471320&mcategoryId=&id=cancer-050207000000.
2. International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. Lyon: International Agency for Research on Cancer [cited 2015 Apr 9]. Available from: http://globocan.iarc.fr.
3. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 2014;46:109-123.
4. Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010;200:454-461.
5. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev 2011;12:1657-1663.
6. National Evidence-based Healthcare Collaborating Agency. A research on evidence-based healthcare for thyroid cancer screening. Seoul: National Evidence-based Healthcare Collaborating Agency; 2012.
7. Choi YJ, Park YL, Koh JH. Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas. Yonsei Med J 2008;49:748-756.
8. Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination. Surg Today 2001;31:763-767.
9. Yamada H, Katoh A, Ishinaga H. Ultrasonographic screening for thyroid cancer in the screening. Nihon Jibiinkoka Gakkai Kaiho 2000;103:13-18.
10. Han YM, Lim SM, Choi HY, Kim Y. Value of ultrasonographic mass screening for thyroid carcinoma in patients undergoing a breast ultrasonography. J Korean Soc Ultrasound Med 2005;24:75-80.
11. Lee YS, Nam KH, Chung WY, Chang HS, Park CS. Postoperative complications of thyroid cancer in a single center experience. J Korean Med Sci 2010;25:541-545.
12. Jung YM, Kim JS, Park JS. Recurrence and complications from the surgical procedure for treating a papillary thyroid carcinoma. J Korean Surg Soc 2001;61:135-141.
13. Kim KB, Suh YJ, Ahn GH, Chun SW, Cho WI, Kim SN, Lee JH. A clinical review of 81 cases of total thyroidectomy. J Korean Surg Soc 1997;52:13-20
14. Polyzos SA, Anastasilakis AD. Clinical complications following thyroid fine-needle biopsy: a systematic review. Clin Endocrinol (Oxf) 2009;71:157-165.
15. Christou N, Mathonnet M. Complications after total thyroidectomy. J Visc Surg 2013;150:249-256.
16. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19:565-612.
17. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: thyroid carcinoma version 2 [Internet]. Fort Washington: National Comprehensive Cancer Network; 2013 [cited 2015 Mar 18]. Available from: http://www.nccn.org/professionals/physician-gls/f-guidelines-nojava.asp.
18. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroendocrine tumors ver-sion I [Internet]. Fort Washington: National Comprehensive Cancer Network; 2013 [cited 2015 Mar 18]. Available from: http://www.nccn.org/professionals/physician-gls/f-guidelines-nojava.asp.
19. Scottish Intercollegiate Guidelines Network. Long term follow up of survivors of childhood cancer [Internet]. Edinburgh: Scottish Intercollegiate Guidelines Network; 2013 [cited 2015 Apr 9]. Available from: http://www.sign.ac.uk.
20. British Thyroid Association; Royal College of Physicians of London. Guidelines for the management of thyroid cancer. 2nded. London: Royal College of Physicians; 2007.
21. rd ed. Seoul: Gukjin P&D; 2009.
22. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T; U.S. Preventive Services Task Force. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med 2009;150:199-205.
23. Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R. Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol 2011;18:5875-5883.